Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Children's Oncology Group
Canadian Cancer Trials Group
Children's Oncology Group
Children's Oncology Group
Eastern Cooperative Oncology Group
Proton Collaborative Group
Children's Oncology Group
Children's Oncology Group